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Abstract
Background: Protein bodies (PBs) are natural endoplasmic reticulum (ER) or vacuole plant-
derived organelles that stably accumulate large amounts of storage proteins in seeds. The proline-
rich N-terminal domain derived from the maize storage protein γ zein (Zera) is sufficient to induce
PBs in non-seed tissues of Arabidopsis and tobacco. This Zera property opens up new routes for
high-level accumulation of recombinant proteins by fusion of Zera with proteins of interest. In this
work we extend the advantageous properties of plant seed PBs to recombinant protein production
in useful non-plant eukaryotic hosts including cultured fungal, mammalian and insect cells.
Results: Various Zera fusions with fluorescent and therapeutic proteins accumulate in induced PB-
like organelles in all eukaryotic systems tested: tobacco leaves, Trichoderma reesei, several
mammalian cultured cells and Sf9 insect cells. This accumulation in membranous organelles
insulates both recombinant protein and host from undesirable activities of either. Recombinant
protein encapsulation in these PBs facilitates stable accumulation of proteins in a protected sub-
cellular compartment which results in an enhancement of protein production without affecting the
viability and development of stably transformed hosts. The induced PBs also retain the high-density
properties of native seed PBs which facilitate the recovery and purification of the recombinant
proteins they contain.
Conclusion:  The Zera sequence provides an efficient and universal means to produce
recombinant proteins by accumulation in ER-derived organelles. The remarkable cross-kingdom
conservation of PB formation and their biophysical properties should have broad application in the
manufacture of non-secreted recombinant proteins and suggests the existence of universal ER
pathways for protein insulation.
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Background
Efficient expression, accumulation and recovery of recom-
binant eukaryotic proteins in their native conformations
are difficult to achieve at reasonable cost in cell-based
biomanufacturing systems [1]. In general, such platforms
are either highly capital-intensive mammalian cell cul-
tures based on secreted proteins [2], or require complex
and inefficient refolding of bacterially expressed proteins
sequestered in insoluble inclusion bodies [3]. Among
eukaryotes, the plant kingdom has evolved cereal seeds to
facilitate massive and extremely stable intracellular accu-
mulation of complex proteins in a dense form that ena-
bles rapid protein mobilization during germination. A key
biological sequestration mechanism of plant seed storage
proteins involves the formation of protein bodies (PBs)
[4-6]. In maize, one type of PB formed in the endoplasmic
reticulum (ER) lumen of endosperm cells [7] contains
zeins, a group of polypeptides which account for more
than half of the total seed protein mass. The 27 kD γ zein
protein bears an N-terminal signal sequence but is
retained intracellularly rather than being secreted even
though it lacks a canonical KDEL/HDEL ER-retention sig-
nal. Instead, γ zein localizes to the periphery of the PBs
surrounding aggregates of other zein proteins [8,9].
Although the mechanism of PB biogenesis is not fully
understood, it appears that the initial presence of γ zein
confers stability to other PB-associated zeins and facili-
tates their sequential assembly in the PB [10]. Surpris-
ingly, heterologous expression of γ zein in plant leaves
results in the ectopic formation of membrane-bound
structures strongly resembling cereal PBs [11,12], suggest-
ing that one or more structural motifs of γ zein may be
responsible for de novo PB formation. This hypothesis is
supported by the finding that a synthetic peptide of the N-
terminal repeat region of γ zein (eight repeating units of
the peptide PPPVHL) was able to self-assemble in vitro
[13] and that both γ zein proline-rich domains, the repeat
region and the so-called Pro-X sequence, each contribute
to PB biogenesis when expressed recombinantly in plants
[12,14].
Here, we describe a protein fusion-based approach for
heterologous protein production via creation of induced
PB-like organelles. Exploiting the natural mechanism of
protein accumulation in seed PBs, we demonstrate that
not only is the Zera domain capable of directing assembly
of PB-like organelles in plant tissues other than seeds, but
this assembly property also extends to a broad range of
non-plant eukaryotes including fungal, insect and mam-
malian cells. These synthetic PBs share many of the advan-
tageous storage properties of bona fide cereal PBs,
including the presence of eukaryotic chaperones to facili-
tate recombinant protein folding, high densities that
allow simple downstream target protein concentration by
PB capture, and insulation of PB contents from proteolytic
and enzymatic activities of the cytosol. Transferring the
seed-type attributes conferred by PB sequestration to
proven eukaryotic cell-based and transgenic expression
systems creates unique opportunities for improving bio-
logical manufacturing. Such an approach is of particular
interest for polypeptides which are poorly secreted, host-
toxic, or otherwise challenging to produce.
Results
The γ zein proline-rich domain (Zera) induces protein 
body-like organelles in eukaryotic cells
To explore if PB attributes could be transferred to diver-
gent eukaryotic lineages and a broad range of fusion pro-
tein partners, we first investigated the induction of PBs in
various hosts expressing fusions of the engineered Zera
domain to fluorescent reporter proteins. Epidermal cells
of tobacco leaves transiently expressing a Zera-ECFP
(enhanced cyan fluorescent protein) construct displayed
well-defined and highly fluorescent foci distributed
throughout the cells (Figure 1A) that were similar in size
and appearance (Figure 1A, see inset) to the natural,
round, 1 to 2 micron PBs present in maize seeds [9]. To
define more specifically the role of Zera in PB formation
we compared these results with the fluorescence of ECFP
preceded by the γ zein N-terminal signal peptide either
with (SPg-ECFP-KDEL, Figure 1B) or without (SPg-ECFP,
Figure 1C) the KDEL C-terminal ER retention signal. The
proteins from construct SPg-ECFP-KDEL accumulated in
the ER (Figure 1B) while those from SPg-ECFP were
secreted (Figure 1C), but neither were capable of inducing
PB-like organelles.
We next investigated the properties of Zera fusions
expressed in animal cells. Chinese hamster ovary (CHO)
cells were transfected stably and transiently with Zera-
ECFP constructs or appropriate non-Zera controls. Dense,
highly fluorescent foci became visible in the cytoplasm
starting two to three days following transfection with
Zera-ECFP (Figure 1D). The contribution of the Zera
domain to storage organelle formation was also investi-
gated using ECFP fused directly to SPg, either with or with-
out a C-terminal KDEL retention signal. Confocal images
obtained from cells expressing SPg-ECFP-KDEL showed a
typical ER pattern (Figure 1E), while fluorescence was dis-
tributed throughout the ER and the Golgi complex (Figure
1F, arrow heads) as expected for secretory transport in
cells expressing SPg-ECFP without KDEL. We also ana-
lyzed by immunoblotting the effect of Zera on partition-
ing of ECFP between cells and the extracellular medium
(Figure 1G). Zera-ECFP and ECFP-KDEL remained exclu-
sively intracellular (Figure 1G, lanes 1 and 3), while ECFP
without Zera or KDEL was secreted efficiently (Figure 1G,
lanes 2). Taken together these results show evidence for
the entry of Zera-ECFP into the initial portion of the secre-
tory pathway but exclusion from ultimate secretion. ThisBMC Biology 2009, 7:5 http://www.biomedcentral.com/1741-7007/7/5
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observation prompted us to investigate whether Zera-
ECFP was sorted terminally in the ER, or was able to exit
this compartment in order to subsequently reach the
Golgi complex. Zera fusions were co-transfected with an
ER membrane protein marker, calnexin, and with a Golgi
protein reporter, a glycosyltransferase fused to YFP. Cal-
nexin was found to co-localize with Zera-ECFP PBs (Fig-
ure 1H to 1J) but no co-localization was observed in CHO
cells between Zera-ECFP and the Golgi reporter protein
(Figure 1K to 1M), consistent with an ER origin of the
Zera-induced PBs.
Filamentous fungi and insect cells were also found to sup-
port the biogenesis of seed-type PBs induced by expres-
sion of Zera fusions. Significant accumulation of Zera-
GFP fusion protein in dense structures was observed in
hyphae of Trichoderma reesei transformed with Zera-GFP
constructs (Figure 1N, arrow). The Zera fusion protein
accumulated intracellularly to ca. 0.1% of fresh weight
when expression was driven by the Trichoderma CbhI pro-
moter. In Spodoptera (Sf9) cells infected with recom-
binant Zera-DsRED baculovirus, the fusion protein also
accumulated in abundant, intensely-fluorescent PB-like
structures (Figure 1P, arrow). In contrast, DsRed controls
expressed without Zera showed fluorescence dispersed
diffusely throughout the cells with no formation of dense
structures (Figure 1O).
Zera stabilizes biopharmaceutical proteins by intracellular 
encapsulation in PB-like organelles
The ability of the Zera domain to segregate proteins away
from normal secretory transport into PB organelles
appears to be conserved between plants, fungi, insects and
animals. In light of these results, we then asked whether
Zera fusions could provide an efficient and universal
means to produce diverse recombinant proteins by stable
encapsulation in ER-derived organelles. To test this
hypothesis, we fused Zera to calcitonin (Ct), epidermal
growth factor (EGF) and human growth hormone (hGH)
sequences and expressed these fusion constructs in vari-
ous eukaryotic hosts. Expression and PB induction by
Zera-Ct, Zera-EGF and Zera-hGH was first investigated
using three different types of mammalian cells following
transient or stable transfection (Figure 2A). Human
HEK293T cells were transfected with Zera-Ct and Zera-
hGH, CHO cells with Zera-hGH and Zera-EGF and Cos1
cells with Zera-EGF. In all cases, Zera fusion proteins were
present intracellularly (Figure 2A, lanes 1) but were not
secreted (Figure 2A, lanes 2). Moreover, immunodetec-
tion of calcitonin in transiently transfected human
(HEK293T), primate (Cos1) and hamster (CHO) cells
expressing Zera-Ct revealed that the recombinant protein
was encapsulated inside PB-like vesicles in all cultured cell
types tested (Figure 2B to 2D).
We also generated CHO cell lines stably expressing Zera-
hGH. The recombinant protein had the expected molecu-
lar weight and was localized to prominent electron-dense
spherical structures that were 1 to 2 microns in size (Fig-
ure 2E to 2F). The membrane bounding the PB-like struc-
tures in Zera-hGH CHO cells was studded with ribosomes
(Figure 2E inset), suggestive of a rough-ER origin, and the
structures were highly enriched in Zera-hGH (Figure 2F).
Immunogold-labeled Zera-hGH appeared in the newly
formed PBs, whereas no significant labeling was observed
in any other cell compartment. Cryosections of non-trans-
fected cells did not contain PB-like structures (data not
shown). Interestingly, despite the presence of heterolo-
gous PB organelles containing high concentrations of
recombinant proteins, transfected mammalian cells were
indistinguishable from non-transfected CHO cells with
respect to proliferation ability and propensity to undergo
apoptosis or necrosis (Figure 2H and 2G, respectively).
This indicates that the accumulation of Zera fusion pro-
teins within PBs does not in itself perturb normal cell
growth and viability.
Proline-rich domain of γ zein (Zera) induces PB-like organelles in plants, CHO cells, insect cells and fungi Figure 1 (see previous page)
Proline-rich domain of γ zein (Zera) induces PB-like organelles in plants, CHO cells, insect cells and fungi. (A) 
Confocal image of PB-like organelles formed in epidermal leaf cells of tobacco transformed with Zera-ECFP (see a higher mag-
nification image in the inset). (B) ER network image of ECFP retained in the ER of tobacco cells expressing SPg-ECFP-KDEL. 
(C) ECFP secretion pattern in tobacco cells transformed with SPg-ECFP construct. (D) PB-like organelles (arrow) in CHO 
cells transfected with Zera-ECFP construct. (E) ER pattern in SPgECFP-KDEL expressing CHO cells. (F) Fluorescent ER and 
Golgi complex (arrowheads) in SPgECFP expressing CHO cells denoting ECFP secretion. (G) Immunoblot using an anti-GFP 
antibody of cell extracts and media of CHO cultured cells expressing Zera-ECFP (lanes 1), ECFP preceded by the γ zein N-ter-
minal signal peptide (SPg-ECFP) (lanes 2) and ECFP-KDEL (from SPg-ECFP-KDEL construct) (lanes 3). CHO cells expressing 
both, Zera-GFP (H) and calnexin-DsRed (ER membrane marker (I) show co-localization of both proteins (merge in J). Co-
expression of Zera-ECFP (K) and a glycosyltranferase labelled with YFP (Golgi reporter in yellow, L), does not result in these 
proteins co-localization (merge in M). (N) Hyphal filaments of Trichoderma reesei transformed with Zera-EGFP showing green 
fluorescent PB-like organelles within hyphae (arrow). (O, P) Baculovirus-mediated expression of DsRed (O) and Zera-DsRed 
(P) in Sf9 cells showing the induction of red fluorescent PBs (arrow in P).BMC Biology 2009, 7:5 http://www.biomedcentral.com/1741-7007/7/5
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Figure 2 (see legend on next page)
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To explore the ability of induced PBs to accumulate biop-
harmaceutical recombinant proteins in plants we gener-
ated transgenic tobacco expressing Zera-EGF and Zera-Ct
fusions. Protein extracts from leaves of homozygous Zera-
EGF and Zera-Ct tobacco plants were analyzed by immu-
noblotting using an antibody (αR8) raised against Zera.
Major bands corresponding to the expected apparent
molecular masses of the respective fusion proteins were
observed (Figure 3A, lanes 1 and 2), with fainter high MW
bands (Figure 3A, arrows) likely reflecting oligomerized
Zera fusions. Similar oligomers have been observed for
native maize γ zein and γ zein proline-rich domains when
expressed in Arabidopsis [12] as well as in protein extracts
from alfalfa plants and in NT-1 tobacco cells expressing
Zera fusions to the F1-V antigen of Yersinia pestis (G Car-
dineau, Arizona State University, personal communica-
tion). In order to evaluate the stability of Zera-EGF and
Zera-Ct fusions in PBs, we compared protein accumula-
tion in flash-frozen leaf material vs. leaves dried at 37°C
for one week after harvest and subsequently stored at
room temperature for five months (such storage typically
results in substantial proteolysis). At the end of the five-
month storage period expression levels of each fusion
protein were determined by immunoblotting. No signifi-
cant difference was found between frozen and dried leaves
(Figure 3B), despite the significant desiccation stress.
Zera-Ct was localized in leaf mesophyl cells of transgenic
plants (Figure 3C to 3E) within 1 to 2-micron membrane-
bound organelles that were heavily decorated with immu-
nogold particles targeting either the Zera domain (Figure
3C) or Ct (Figure 3D). No significant immunolabeling
was observed in the cell wall, nucleus, chloroplasts or
other organelles. The major ER chaperone BiP was also
detectable by immunogold within the PB-like structures
(Figure 3E) suggesting that the process of PB formation
may involve incorporation of pre-existing ER-resident
proteins into these structures. BiP is known to be present
in cereal PBs where it is thought to play a role in storage,
protein folding and assembly [15]. Hence, co-localization
of Zera-Ct and BiP in the PB-like organelles formed in
tobacco leaves indicates that the recombinant fusion pro-
teins are associated closely with chaperones that may
mediate eukaryotic protein folding in the ER. The trans-
genic plants grew and developed normally and were not
adversely affected despite the presence of PB organelles
and large amounts of fusion protein.
Several biopharmaceutical proteins fused to Zera remain encapsulated in PB-like organelles in transfected mammalian cells Figure 2 (see previous page)
Several biopharmaceutical proteins fused to Zera remain encapsulated in PB-like organelles in transfected 
mammalian cells. (A) Western blots of Zera-Ct, Zera-hGH and Zera-EGF demonstrating accumulation inside transfected 
mammalian cells (lanes 1) without significant secretion into the cell culture media (lanes 2). (B-D) Immunodetection of Zera-
Ct in 293T (B), Cos1 (C) and CHO (D) transfected cells using an anti-calcitonin antibody and FITC-labeled secondary anti-
body. Green fluorescence indicates recombinant protein accumulation in PB-like organelles in all three cases. (E, F) Electron 
microscopy images of a CHO cell line stably transfected with Zera-hGH; (E) CHO cell showing a PB-like organelle (PB) con-
taining electron-dense structures surrounded by a classical rough-ER membrane (see ribosomes in inset). (F) Immunodetec-
tion of Zera-hGH recombinant protein in PBs induced in transfected CHO cells. Cryosections were incubated with an anti-
hGH antibody and labeled with Protein A-gold particles (10 nm). PB, protein body-like organelle; M, mitochondria; ER, endo-
plasmic reticulum. (G) Viability of CHO cells stably transfected with Zera-ECFP and Zera-EGF. Relative percentages of living, 
necrotic and apoptotic transfected cells were compared to those of non-transfected controls (CHO WT). (H) Proliferation 
profiles of CHO cells expressing Zera-hGH and Zera polypeptides as compared to non-transfected CHO WT cells over 1 to 
4 days of incubation.
Zera stabilizes biopharmaceutical proteins in transformed  plants Figure 3
Zera stabilizes biopharmaceutical proteins in trans-
formed plants. (A) Immunodetection with anti-Zera anti-
body (anti-R8) of Zera-EGF (lane 1) and Zera-Ct (lane 2) in 
leaves of stably-transformed tobacco plants. Arrows indicate 
oligomers, and C denotes lanes containing proteins from 
non-transformed controls. (B) Stability of Zera-EGF and 
Zera-Ct fusion proteins in desiccated leaves of transgenic 
tobacco plants. Protein extracts from equivalent amounts of 
tissue were loaded in each lane and relative accumulation 
was visualized by anti-Zera immunoblotting of protein 
extracts from fresh (F) and desiccated (D) leaves. (C-E) 
Immunogold labeling of Zera-Ct inside newly formed PBs in 
transformed tobacco leaves using anti-R8 (C), anti-calcitonin 
(D) and anti-BiP (E) antibodies. PB, induced PBs.
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We investigated the accumulation of EGF in insect cells by
baculovirus infection with Zera-EGF. Sf9 cells accumu-
lated Zera-EGF to remarkably high levels, exceeding 15%
of total protein (Figure 4D lane 2). In contrast, EGF accu-
mulated to much lower levels (Figure 4D lane l) in cells
infected with virus containing constructs lacking Zera. In
fact, EGF in these cells was not detectable by silver or
Coomassie staining, and was only faintly visualized by
immunoblot (Figure 4D arrowhead). Cryosections of
Zera-EGF infected cells (Figure 4B) showed the presence
of abundant electron-dense structures which were absent
in non-infected Sf9 cells (Figure 4A). These PB-like parti-
cles were heavily decorated by anti-EGF immunogold
(Figure 4C).
Sf9 insect cells accumulate high levels of Zera fusions in induced PBs Figure 4
Sf9 insect cells accumulate high levels of Zera fusions in induced PBs. (A-C) Electron micrographs of control and 
Zera-EGF Sf9 cells. (A) Cells immediately post-infection. (B) Electron-dense PB-like structures (PB) visible at 2 days post-
infection. (C) Immunogold labeling of Zera-EGF expressing Sf9 cells using anti-EGF antisera. N: nuclei; M: mitochondria; ER. 
endoplasmic reticulum; PB: PB-like organelles. (D) Silver stained SDS-PAGE (left) and immunoblot (right) of protein extracts 
from Sf9 cells expressing Zera-EGF (lanes 2), expressing EGF alone (lanes 1) and non-infected control cells (lanes C). Note the 
high accumulation of Zera-EGF in lanes 2 (arrows) compared with equivalent non-Zera EGF-expressing cell extracts (lane 1, 
arrowhead).
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To evaluate the efficiency of recombinant protein produc-
tion in induced PBs we compared the accumulation level
of recombinant EGF and hGH proteins expressed with
and without Zera in tobacco plants and insect cells (Table
1). In both expression systems, fusion with Zera resulted
in marked increases in target protein accumulation associ-
ated with PB induction.
Induced PBs facilitate recombinant protein recovery
One of the most significant bottlenecks in non-secreted
recombinant protein production is the recovery of the
protein from the expression host. We explored whether
Zera-protein fusions could be isolated from crude cell or
tissue extracts by virtue of the high density of Zera-
induced PBs (Figure 5). Leaf homogenate extracts from
Zera-EGF transgenic tobacco plants were fractionated on
density gradients and analyzed by gel electrophoresis and
immunoblotting using anti-Zera and anti-BiP antibodies
(Figure 5A to 5C). Most of the Zera-EGF protein was
recovered in the dense 1.18 to 1.26 g/cm3 sucrose gradient
interface (Figure 5A and 5C, F3), with some present in the
ER fraction (Figure 5A, F2). BiP also partitioned with the
PB-containing fraction (Figure 5B, F3), in agreement with
the immunoelectron microscopy findings for Zera-Ct
(Figure 3E). Zera-protein fusions could also be recovered
by density from transformed filamentous fungi and insect
cells extracts. In Trichoderma (Figure 5D), Zera-GFP was
detectable by both direct Coomassie staining and immu-
noblotting following gel electrophoresis of dense particles
isolated on sucrose density gradients. In controls lacking
Zera no GFP could be isolated in high-density fractions
(Figure 5D, compare lanes F3). As in plants and fungi,
dense PB-like structures from Zera-EGF-expressing Sf9
cells were readily isolated by density gradients (Figure 5E).
Zera-EGF fusion protein but not EGF could be recovered
from crude lysates in the 1.18 to 1.26 g/cm3 sucrose gradi-
ent interface (Figure 5E, lanes F3). It should be noted that
low-speed direct centrifugation of the homogenates,
while less efficient than gradients (which enriched the
fusion protein up to 85% in a single density separation
following cell lysis) was also able to effect substantial con-
centration and purification of Zera fusions (data not
shown).
Discussion
Our results indicate that in a variety of eukaryotic cells the
N-terminal proline-rich portion of γ zein, the Zera assem-
bler domain, is by itself sufficient to direct recombinant
fusion protein accumulation within de novo-produced
storage organelles similar to the PBs of seeds. These
organelles retain many of the beneficial characteristics of
cereal seed PBs, including the physical properties of high
local concentration within a discrete membrane-bound
structure that allows efficient isolation by simple density-
based protocols, sub-cellular sequestration that facilitates
protein accumulation preventing adverse metabolic inter-
actions, and association with molecular chaperones that
may facilitate folding and enable functional and stable
expression of enzymes and human proteins. Remarkably,
the mechanism by which the ER of cereal seeds segregates
storage proteins away from normal secretory transport
and accumulates them into PB organelles appears to be
conserved between plants, fungi, insects and animal cells.
This finding suggests that PB biogenesis may be related to
general cis-mediated biophysical interactions of the ER
with the Zera structure rather than depending on trans-
factor associated processes such as receptor-mediated sig-
naling. The mechanism by which Zera forms these novel
cell organelles is not yet fully characterized, but an impor-
tant contributing factor is likely to be the physico-chemi-
cal properties of the PPPVHL repeat domain of Zera. This
domain folds in vitro into an amphipathic poly-Proline II
conformation [13] that in turn forms an expanded helix
able to assemble both with itself [16] and with membrane
lipids [17]. Besides the specific properties derived from its
amphipathic nature, the Zera domain also contains six
cysteine residues, which may serve to stabilize nascent
assembled Zera complexes via intermolecular disulfide
bonds. Studies of PB formation in tobacco plants express-
ing a chimeric storage protein created by fusion of the
Table 1: Accumulation levels of proteins expressed with Zera and without Zera
Tobacco Sf 9 Cells
g POI/Kg fresh biomass +/- SD μg POI/106 cells +/- SD
Zera-EGF 0.5 +/- 0.1 5.6 +/- 2.01
EGF 0.005 +/- 0.002 0.5 +/- 0.032
Zera-hGH 3.2 +/- 1.39 88 +/- 30.3
hGH 0.25 +/- 0.09 6.18 +/- 1.13
POI: Product of interest; SD: standard deviation; EGF and hGH recombinant proteinsBMC Biology 2009, 7:5 http://www.biomedcentral.com/1741-7007/7/5
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PBs isolation by density and Zera-fusion proteins recovery Figure 5
PBs isolation by density and Zera-fusion proteins recovery. (A-C) Protein analysis of fractions collected from a 
sucrose gradient of Zera-EGF tobacco leaf homogenates. (A) Immunoblot (αR8 antibody) shows Zera-EGF primarily in the 
dense F3 fraction (1.18 to 1.26 g/cm3 interface, arrow). (B) Immunoblot using anti-BiP antibody indicates that the soluble ER 
chaperone co-sediments with Zera-EGF in the F3 fraction. (C) Silver stained SDS-PAGE of sucrose fractions showing the 
enrichment of Zera-EGF in the F3 fraction. (D) Subcellular fractionation of homogenates of T. reesei expressing Zera-GFP 
(right) and GFP-KDEL (left). The analysis of fractions by Coomassie staining shows highly concentrated Zera-GFP in the dense 
fraction F3 (1.18 to 1.26 g/cm3 interface, arrow). (E) Protein analysis by gel electrophoresis and silver stain of fractions col-
lected from sucrose gradients of Zera-EGF (left) and EGF (right) Sf9 expressing cells. Recombinant Zera-EGF fusion is concen-
trated in the dense fraction F3 (arrow) where PBs sediment.
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maize γ zein proline-rich domain and the legume storage
protein phaseolin [14] suggests that γ zein Cys residues
contribute to fusion protein polymerization and accumu-
lation in the ER [18].
Recombinant protein accumulation was clearly enhanced
by using Zera. This enhancement has been observed with
several proteins expressed in different eukaryotic hosts
with and without fusion to Zera. Recombinant hGH accu-
mulated 13 times more when transiently expressed as
Zera-hGH in Nicotiana benthamiana, while the differential
accumulation of recombinant EGF as a fusion was 100-
fold greater than EGF alone (Table 1). These high levels of
fusion protein accumulation in PBs suggest that in addi-
tion to organellar sequestration, Zera protein condensa-
tion may also provide a mechanism for such fusions to
evade the normal ER degradative pathways. The ER-asso-
ciated degradation (ERAD) mechanism [19,20] is induced
transcriptionally in all eukaryotic cells in response to the
presence of unfolded proteins [21]. This mechanism is
conserved from yeast to humans and affects both endog-
enous and heterologous proteins. High accumulation of
Zera fusions assembled into heterologous PBs may there-
fore reflect poor recognition by the ERAD pathway and/or
inefficient delivery of fusions to the cytosol for proteolysis
following ERAD pathway entry.
In addition, accumulation of recombinant Zera fusion
proteins apparently does not alter normal host cell growth
and development, and neither predisposes such cells to
apoptosis nor perturbs the normal functionality of the
secretory pathway. It is well known that if the rate of syn-
thesis of a given protein exceeds the rates of folding and
degradation the resultant over-accumulation in the ER
usually triggers apoptosis [22]. Our results suggest that
this is not the case for PB-accumulated proteins, as we
observed that 1) transgenic Zera plants germinated, were
fertile and developed identically to wild-type plants; 2)
apoptosis profiles and proliferation rates of CHO cells
over-expressing Zera fusion proteins were similar to non-
transfected CHO cells; and 3) fungal cells expressing Zera
fusions grew normally and vigorously despite accumulat-
ing large intracellular PBs. Naturally occurring ER-derived
structures sequestering aberrant proteins have been
observed previously in mammals. Such structures include
the so-called Russell bodies found in non-apoptotic
plasma cells of multiple myeloma and AIDS patients [23].
These structures are thought to arise from dilated ER cis-
ternae that sequester condensed immunoglobulins that
might otherwise trigger deleterious cellular responses
[24]. The broad species conservation of PB induction may
therefore reflect an ancestral protective response to miti-
gate the potentially adverse effects of protein over-accu-
mulation in the ER. Taken together, our observations of
high intracellular accumulation, enhanced recombinant
protein stability, and the lack of adverse metabolic conse-
quences for the expressing host cell all suggest that seques-
tration within membrane-bound PBs serves as an effective
means to isolate the cell and recombinant target protein
from one another.
An additional key consideration for recombinant protein
production is the efficiency of downstream recovery and
purification [25]. Packaging of recombinant protein into
dense organelles that are easily concentrated from cell
lysates provides a significant enrichment of pre-purifica-
tion titer prior to chromatographic separation or capture
steps. The resulting density-fractionated Zera protein
fusions can be readily purified following disaggregation
under mild reducing conditions. This creates an opportu-
nity to design improved downstream purification proto-
cols that may be less costly than current approaches.
Currently, downstream purification comprises the bulk of
the costs associated with recombinant protein biophar-
maceutical manufacture.
Conclusion
Zera sequence provides an efficient and universal means
to produce recombinant proteins by accumulation in ER-
derived organelles. This intracellular storage and seques-
tration system evades the normal cellular protein degrada-
tion mechanisms and does not perturb cell metabolism.
The PB structures formed by Zera fusions share many of
the advantageous storage properties of bona fide cereal
seed PBs, including the presence of eukaryotic chaperones
to facilitate recombinant protein folding, high densities
that allow simple downstream target protein concentra-
tion by PB capture, and insulation of PB contents from
proteolytic and enzymatic activities of the cytosol. Trans-
ferring the seed-type attributes conferred by PB sequestra-
tion to proven eukaryotic cell-based and transgenic
expression systems creates unique opportunities for
improving biological manufacturing. Such an approach is
of particular interest for polypeptides which are poorly
secreted, host-toxic, or otherwise challenging to produce.
Methods
Plasmid constructs
Plasmid pUC18Zera coding for the Zera N-terminal γ zein
coding sequence (Zera, RX3 sequence) [26] was obtained
after amplification of the DNA sequence coding for the
Zera domain by PCR using the vector pKSG2 [27] as tem-
plate and suitable oligonucleotides as primers. The syn-
thetic genes and cDNA sequences for mature calcitonin
(Ct), epidermal growth factor (EGF), human growth hor-
mone (hGH) and cyan (ECFP), green (EGFP) and red
(DsRED) fluorescent proteins were fused to the 3' end of
Zera N-terminal γ zein-coding sequence in the plasmid
pUC18Zera. When desired, sequences coding for specificBMC Biology 2009, 7:5 http://www.biomedcentral.com/1741-7007/7/5
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protease cleavage sites (Factor Xa or Enterokinase) were
included between Zera and fused gene sequences.
To transform mammalian cells the fusion protein coding
sequences Zera-Ct, Zera-EGF, Zera-hGH and Zera-ECFP
from pUC18-derived plasmids were introduced in the
mammalian transfection vector pcDNA3.1(-) (Invitro-
gen) under the human cytomegalovirus immediate-early
(CMV) promoter to give the constructs p3.1ZeraCt,
p3.1ZeraEGF, p3.1ZerahGH and p3.1ZeraECFP. Plasmid
p3.1ZeraSTOP was used to express the Zera polypeptide
alone and contained the Zera cDNA with a stop codon at
the 3' end. Finally, plasmid pECFP-N1 (Clontech) was
used as the template to obtain SPg-ECFP and SPg-ECFPK-
DEL protein coding sequences by fusion of the γ zein sig-
nal peptide (SPg) with ECFP sequences containing or not
containing the KDEL sequence at the 3' end, using two 5'
overlapping primers and suitable reverse primers. PCR
products were introduced in pCR-Blunt (Invitrogen) and
the new plasmids were named pCRSPgECFP and
pCRSPgECFPKDEL. Finally the mammalian transfection
vectors p3.1SPgECFP and p3.1SPgECFPKDEL were
obtained.
For plant transformation, the Zera-ECFP, SPg-ECFP and
SPg-ECFPKDEL protein-coding sequences were intro-
duced into the binary plant vector pCambia 2300 http://
www.cambia.org and the Zera-Ct and Zera-EGF-coding
DNAs were introduced into the binary vector pBin19. All
fusion sequences were under the control of the enhanced
35S cauliflower mosaic virus (CaMV) promoter and the
resulting plant transformation vectors were named,
respectively, pCZeraECFP, pCSPgECFP, pCSPgECFPK-
DEL, p19ZeraCt and p19ZeraEGF.
For insect cells infection, Zera-EGF and Zera-DsRED DNA
sequences were introduced into the vector pBacPak8
(Clontech) to obtain vectors pBacPak8ZeraEGF and
pBacPak8ZeraDsRED. Plasmids pBacPak8EGF and
pBacPak8DsRED were used as controls for EGF and
DsRED non-fused protein expression in insect cells. The
construct containing the coding sequence of an improved
monomeric Ds Red protein (mCherry) was kindly pro-
vided by Dr RY Tsien [28].
Two constructs for expression of EGFP in Trichoderma ree-
sei  were created in the plasmid pMS186 essentially as
described [29] using the plasmids pUC18Zera and pSM1-
EGFP [30] as templates in PCR. The forward primer
encoded the cbhI signal sequence that was fused to the 5'
terminus of the Zera peptide sequence in the new
pMS186ZeraGFP construct containing the Zera-EGFP
coding sequence, whereas the EGFP control construct
pMS186GFPHDEL included the HDEL C-terminal ER
retention signal sequence.
Cell culture, transfections and transformations of 
mammalian cell culture, fungi, plants and insect cells
Mammalian cell cultures
Cos 1 and 293T cells were grown in DMEM medium
(GIBCO) and CHO cells in HAM F-12 (GIBCO) medium,
both media supplemented with 10% fetal calf serum
(PAA) and 2 mM L-Glutamine (Sigma). Monolayer cul-
tures were maintained at 37°C, 5% CO2 and 100% rela-
tive humidity. Stable and transient transfection of
cultured cells was done by the lipofectamine-based
method (Invitrogen) according to the manufacturer's
instructions. Stably transfected CHO clonal cell lines
expressing the protein fusions Zera-hGH and Zera-ECFP
were selected in the supplemented HAM F-12 medium
containing 500 μg/ml geneticin (Invitrogen).
Plants
Nicotiana tabacum (var. Wisconsin 38) plants were stably
transformed with Agrobacterium tumefaciens containing
the binary vectors p19ZeraCt or p19ZeraEGF by leaf discs
infection as described [31]. For transient transformation,
Nicotiana benthamiana plants were agroinfiltrated by
syringe method into the abaxial side of 3 to 5-week-old
leaves [32]. The binary plant vectors pCZeraECFP,
pCSPgECFP and pCSPgECFPKDEL were used together
with the HC-Pro silencing supressor construct [33].
Insect cells
Spodoptera frugiperda (Sf9) insect cells (Invitrogen) were
grown in suspension or as monolayers at 28°C in serum-
free SF900 SFM Medium (Gibco). Recombinant baculovi-
rus were produced by Sf9 co-transfection with flashBAC
DNA (from OET) and transfer vectors pBacPak8 contain-
ing the Zera-DsRED, DsRED, Zera-EGF or EGF coding
sequences according the manufacture's recommenda-
tions. Recombinant viruses were titrated [34] and monol-
ayer Sf9 cultures were infected with the recombinant
baculovirus at multiplicity of infection (MOI) of 10 to 12.
Fungal culture
Expression vectors were introduced into the T. reesei strain
RutC-30 [35] essentially as described [36] and transform-
ants were selected on plates containing 125 μg/ml of
hygromycin B. The transformants were streaked on selec-
tive medium containing lactose for induced expression
and screened by fluorescence microscopy. Mycelia from
the transformants producing the highest amounts of GFP
were harvested by filtration.
Protein extraction and immunoanalysis
Total soluble proteins (TSPs) from transfected cells and
tissues were extracted in lysis buffer containing 0.5% SDS
and 200 mM DTT for 1 hr at room temperature. The vari-
ous resulting extracts were centrifuged at 10000 × g for 30
min at 4°C and TSPs were separated on 12 to 15% SDSBMC Biology 2009, 7:5 http://www.biomedcentral.com/1741-7007/7/5
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polyacrylamide gels and the proteins were detected by
staining or by immunoblot using the indicated antibod-
ies. The αR8 antiserum was raised in rabbits injected with
the synthetic γ zein repeat domain (PPPVHLx8) coupled
to the keyhole limpet haemocyanin (KLH) protein used as
a carrier. Anti-GFP IgGs were from Molecular Probes.
Anti-BiP antiserum was raised in rabbits injected with the
recombinant C-terminal half (without the HDEL
sequence) of tobacco BiP sequence produced in E. coli.
Anti-Ct antiserum was raised in rabbits injected with a
synthetic calcitonin peptide coupled to the KLH protein.
Rabbit polyclonal anti-calnexin, anti-EGF and anti-
DsRED were from Abcam. Anti-hGH was raised in rabbits
injected with synthetic human growth hormone (hGH,
kindly provided by Dr E Giralt, University of Barcelona).
To quantify the accumulation level of Zera fusions, pro-
teins were extracted from biomass (frozen leaves and Sf9
cell pellets) with EX buffer (100 mM Tris-HCl pH 8, 50
mM KCl, 5 mM MgCl2, 10 mM EDTA, 0.5 M NaCl) in a
ratio 1:10 (w/v). An aliquot of the samples was diluted
1:50 in ELISA buffer (12.5 mM sodium borate, 0.1% SDS,
50 mM TCEP, 8 M urea) and quantified by ELISA (NUNC
Maxi Sorp plates) using an α-R8 antibody and purified
Zera-EGF and Zera-hGH as standards. EGF and hGH
expressed without Zera were quantified by ELISA using
the respective commercial kits from Peprotech and Roche
and following the manufacturers protocol.
Viability and proliferation analysis
Viability assays were done by using the Vybrant Apoptosis
Assay from Molecular Probes and following the manufac-
turer instructions. Proliferation profiles were determined
by using the CyQuant Cell Proliferation Assay (Invitro-
gen) as indicated by the manufacturers.
Subcellular fractionation
Transfected mammalian cells were suspended (2 to 3 ×
106 cells/ml) in homogenization buffer HA (10 mM Tri-
ethanolamina (TEA) pH 7.4, 1 mM EDTA, 200 μM PMSF)
containing 8.5% (w/w) sucrose and were homogenized in
a Dounce homogenizer by around 30 up and down
strokes. Cell rupture was monitored by staining with
0.005% (w/v) trypan blue and finally the homogenate
was clarified by centrifugation for 5 min at 300 × g.
Infected Sf9 insect cells (1 to 2 × 106  cells/ml) were
homogenated on PBP5 Buffer (10 mM Hepes pH 7.4, 2
mM EDTA) containing 10% (w/w) sucrose and Complete
Protease Inhibitor Cocktail (Invitrogen) using a Potter-
Elvehjem homogenizer during 6 min in ice. Transfected
Trichoderma filamentous fungi were ground in a mortar
with liquid nitrogen and homogenized in PBP5 Buffer in
a polytron (IKA T25 Basic) for 1 min at 12000 rpm on ice.
To remove tissue debris, the suspension was centrifuged
10 min at 200 × g. Transgenic tobacco leaves were ground
in a mortar at 0°C in the HB homogenization buffer (Tris
100 mM pH 8, KCl 50 mM, MgCl2 5 mM, EDTA 1 mM)
containing 10% (w/v) sucrose and protease inhibitors.
The homogenate was additionally ground using a poly-
tron (IKA T25 Basic, 10 strokes at 12000 rpm) and filtered
through four layers of Miracloth (22 to 24 μm, Calbio-
chem) to remove tissue debris before to be centrifuged at
50 × g for 5 min at 4°C. The resulting clarified homoge-
nates from the various tissues were loaded onto multistep
sucrose gradients (1.08, 1.13, 1.18 and 1.26 g/cm3) buff-
ered with the corresponding homogenization buffer. The
gradients were centrifuged at 4°C for 2 hr at 80000 × g in
a Beckman SW40 Ti rotor. Equivalent aliquots of superna-
tant, interphase fractions and pellet were analyzed by
SDS-PAGE and immunoblot by using specific antibodies.
Electrophoretic protein patterns were also analyzed by
Coomassie blue or silver staining.
Immunocytochemistry and imaging
Confocal microscopy
Transfected mammalian and insect cells were fixed for 10
min in 3.7% paraformaldehyde and after washing were
incubated with specific antibodies for 1 hr. The primary
antibodies were detected with anti-rabbit antibodies con-
jugated to Alexa Fluor 488 or Alexa Fluor 555 dyes
(Molecular Probes). Cells expressing fluorescent reporters
were simply washed and fixed. Sections of leaf tobacco tis-
sues and T. reesei hyphae transformed with fluorescent-
derived sequences were mounted in water or Mowiol for
direct confocal observation. Micrographs were obtained
by using the confocal laser scanning microscope Leica TCS
SP (Heidelberg, Germany).
Green fluorescent images were collected at 488 nm excita-
tion using an emission window set at 495 to 535 nm. Red
fluorescent images were collected after 543 nm excitation
using a 550 to 600 nm emission window. Cyan fluores-
cent images were collected at 458 nm excitation and an
emission window of 470 to 530 nm.
Electron microscopy
Mammalian cells from wild-type CHO and p3.1ZerahGH
stably transfected cells were fixed at 4°C with 2.5% glutar-
aldehyde in PHB (100 mM phosphate buffer pH 7.4).
After washing, the samples were postfixed at 4°C with 1%
osmium tetroxide in PHB containing 0.8% potassium fer-
ricyanide. Then the samples were dehydrated in acetone,
infiltrated with Epon resin for 2 days, embedded in the
same resin and polymerised at 60°C for 48 hr. Ultrathin
sections stained with 2% uranyl acetate and lead citrate
were observed in a JEM-1010 electron microscope (Jeol,
Japan). For immunolabeling wild-type and transfected
CHO cells, ultrathin cryosections were prepared using an
ultracryomicrotome (Leica EM FCS, Austria). Ultrathin
sections were incubated with antibodies anti-hGH (1/
100) or αR8 antiserum (1/700) and protein A-colloidalBMC Biology 2009, 7:5 http://www.biomedcentral.com/1741-7007/7/5
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gold (10 nm). Sections were observed in a JEM-1010 elec-
tron microscope (Jeol, Japan). Leaves from wild-type and
p19ZeraCt stably transformed tobacco plants were fixed
by vacuum infiltration with 1% glutaraldehyde and 2.5%
paraformaldehyde in 20 mM phosphate buffer, pH 7.4,
for 1 hr at room temperature. Samples were dehydrated
and embedded in Lowicryl K4M resin. Immunochemistry
was performed essentially as described in [12] using anti-
bodies anti-Ct (1/500), anti-BiP (1/500), and anti-γ zein
(1/1500) and protein A-colloidal gold (15 nm). Sections
were examined under an electron microscope (Phillips
EM301, Eindhoven, The Netherlans). In all cases non-
immune serum was used as control.
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